Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Broadway Financial Corporation is a banks-regional business based in the US. Broadway Financial Corporation shares (BYFC) are listed on the NASDAQ and all prices are listed in US Dollars. Broadway Financial Corporation employs 62 staff and has a trailing 12-month revenue of around USD$12.5 million.
|52-week range||USD$1.04 - USD$4.45|
|50-day moving average||USD$2.1703|
|200-day moving average||USD$1.8255|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.007|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Broadway Financial Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Broadway Financial Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Broadway Financial Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 214x. In other words, Broadway Financial Corporation shares trade at around 214x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
|Revenue TTM||USD$12.5 million|
|Operating margin TTM||0.7%|
|Gross profit TTM||USD$11.3 million|
|Return on assets TTM||-0.03%|
|Return on equity TTM||-0.27%|
|Market capitalisation||USD$61.1 million|
TTM: trailing 12 months
There are currently 216,578 Broadway Financial Corporation shares held short by investors – that's known as Broadway Financial Corporation's "short interest". This figure is 95.5% up from 110,798 last month.
There are a few different ways that this level of interest in shorting Broadway Financial Corporation shares can be evaluated.
Broadway Financial Corporation's "short interest ratio" (SIR) is the quantity of Broadway Financial Corporation shares currently shorted divided by the average quantity of Broadway Financial Corporation shares traded daily (recently around 2.0 million). Broadway Financial Corporation's SIR currently stands at 0.11. In other words for every 100,000 Broadway Financial Corporation shares traded daily on the market, roughly 110 shares are currently held short.
However Broadway Financial Corporation's short interest can also be evaluated against the total number of Broadway Financial Corporation shares, or, against the total number of tradable Broadway Financial Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Broadway Financial Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Broadway Financial Corporation shares in existence, roughly 10 shares are currently held short) or 0.0129% of the tradable shares (for every 100,000 tradable Broadway Financial Corporation shares, roughly 13 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Broadway Financial Corporation.
Find out more about how you can short Broadway Financial Corporation stock.
We're not expecting Broadway Financial Corporation to pay a dividend over the next 12 months.
Broadway Financial Corporation's shares were split on a 2:1 basis on 2 December 2002. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Broadway Financial Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Broadway Financial Corporation shares which in turn could have impacted Broadway Financial Corporation's share price.
Over the last 12 months, Broadway Financial Corporation's shares have ranged in value from as little as $1.04 up to $4.45. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Broadway Financial Corporation's is 0.9984. This would suggest that Broadway Financial Corporation's shares are less volatile than average (for this exchange).
Broadway Financial Corporation operates as the holding company for Broadway Federal Bank, f.s.b. that provides various banking products and services in the United States. It accepts various deposit accounts, including savings accounts, checking accounts, NOW accounts, money market accounts, and fixed-term certificates of deposit. The company also mortgage loans, which are secured by multi-family residential properties; single family residential properties; and commercial real estate, including churches, as well as commercial business, construction, and consumer loans. In addition, it invests in securities issued by federal government agencies, residential mortgage-backed securities, and other investments. The company operates through three branch offices. Broadway Financial Corporation was founded in 1946 and is headquartered in Los Angeles, California.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.